1.Integration: a method for evaluating voltage-dependent transient outward potassium currents in pharmacology
Deli DONG ; Zhijie SUN ; Jundong JIAO ; Peng YUE ; Qinghui WANG ; Zhiwei FANG ; Baofeng YANG
Chinese Journal of Pharmacology and Toxicology 2005;19(1):64-69
AIM To evaluate the integration method for analysis of voltage-dependent Ca2+-independent transient outward K+ currents (Ito) in pharmacology. METHODSThe inactivation phases of Ito were best fitted by the sum of two or three exponentials equations. The area under the raw current curves (AUC) was obtained by the integration of exponential equations. The AUC normalized to the cell capacitance represented the net K+ charge flow during any depolarized duration and was as the index for comparison. Calcineurin overexpression transgenic (TG) mice showed downregulation of Ito. These data were tested by the integration method. RESULTS AUC obtained from three or two exponentials fittings was calculated as: AUC=A1τ1+A2τ2+A3τ3+A0t-A1τ1e-t/τ1-A2τ2e-t/τ2-A3τ3e-t/τ3 or AUC=A1τ1+A2τ2+A0t-A1τ1e-t/τ1-A2τ2e-t/τ2. The 50% and 90% action potential duration (APD50, APD90) in ventricular myocytes of mice are about 10 ms and 30 ms, respectively. AUC at 10 ms (AUC50, AUC of 50% APD) and 30 ms (AUC90, AUC of 90% APD) in left ventricle cardiomyocytes of wild type (WT) and TG mice were normalized to the cell capacitance. The normalized AUC50 and AUC90 of WT group were significantly more than those of TG group, which was consistent to the prolongation of APD in TG mice and the previous published results(downregulation of components of Ito in TG mice). CONCLUSION The integration method was an ideal way for analysis of transient outward K+ currents in pharmacology.
2.DNA polymerase iota and cancer
Haoyao SUN ; Jundong ZHOU ; Xingjun MENG ; Xiaoqing LI ; Jian YU ; Jinchang WU
Journal of International Oncology 2014;41(10):731-733
DNA polymerase iota (Polt),as well as Revl,Polκ and Polη,are all Y family DNA polymerases,which are able to replicate damaged DNA via translesion synthesis pathway.However,Pol(t) has the lowest fidelity among all DNA polymerases in both correct and inaccurate DNA templates.Also Pol(t) can bypass certain DNA damages and accumulate mutations.Recent studies show that the aberrant expression of Pol(t) is observed in human uveal melanoma,breast cancer,bladder cancer,lung cancer and esophageal cancer,which may contribute to the tumorigenesis and progression of tumor.The special role of Pol(t) in replicating damaged DNA may contribute to the resistance in oncotherapy.
3.Study on the framework design and practice of Hangzhou′s public hospital reform
Xiaohe WANG ; Hao ZHANG ; Xianhong HUANG ; Jianrong TENG ; Zhonghua ZHAO ; Weiwu CUI ; Jundong SUN ; Beifang YUAN
Chinese Journal of Hospital Administration 2019;35(6):457-461
Reform of public hospitals is key to the healthcare system reform.This article introduced how Hangzhou implemented such a reform of " Hangzhou characteristics" by referring to the hospital reform framework of the World Bank, and the theoretical achievements and practical experiences of domestic public hospitals′reform.Led by the service concept of " Medicine has its limitations but we have the courage to overcome, service is boundaryless and we must pursue excellence" , Hangzhou has established a public hospital value system of " reorientation to public welfare".The smart healthcare system serves as a focus, to support the delicacy management of the hospitals. The construction of hierarchical medical care system functions as the pillar, to support the coordinated development of hospitals, primary health institutions and public health institutions.This way a public hospital comprehensive reform mode is established featuring " one value system, 2 levels of organization structure, 6 mechanisms, and 19 supporting measures ". Its experiences may serve as reference to streamline hospital internal operation and external cooperation mechanism.
4.Effect of RAD18-siRNA on proliferation and chemotherapy sensitivity of human esophageal squamous cell carcinoma ECA-109 cells.
Pengrong LOU ; Xiaonan SUN ; Jundong ZHOU ; Shitao ZOU
Journal of Zhejiang University. Medical sciences 2016;45(4):364-370
To investigate the effect of RAD18-siRNA on cell proliferation and chemotherapy sensitivity of esophageal squamous cell carcinoma (ESCC) ECA-109 cells.RAD18-siRNA was transfected into human ECA-109 cells by Lipofectamine 3000. Quantitative PCR and Western blot were performed to detect RAD18 and CyclinD1 expression; CCK-8 assay was used to determine cell proliferation and chemotherapy drug sensitivity; flow cytometry was used to determine cell cycle. Correlation between RAD18 and CyclinD1 mRNA expression was analyzed by Pearson's correlation.Compared with non-transfected cells, the expression of RAD18 in RAD18-siRNA group was significantly decreased (<0.05). The cell proliferation was inhibited (<0.05) and the cell number of G1 phase was increased, G2/M phase cells decreased (<0.05) in RAD18-siRNA group. After treatment with different concentrations of cisplatin or 5-FU, the survival rate of the two cell groups was reduced (all<0.05), and the IC50 of RAD18-siRNA group was significantly lower than that of non-transfected group (<0.05). The mRNA expression of RAD18 was positively correlated with CyclinD1 expression in ESCC tissues(=0.478,<0.01).Down-regulated expression of RAD18 can decrease the cell proliferation and increase chemo-sensitivity of ESCC cells, and CyclinD1 may participate in the process.
Adjuvants, Pharmaceutic
;
pharmacology
;
Carcinoma, Squamous Cell
;
drug therapy
;
physiopathology
;
Cell Cycle
;
Cell Line, Tumor
;
Cell Proliferation
;
drug effects
;
Cisplatin
;
pharmacology
;
Cyclin D1
;
drug effects
;
genetics
;
DNA-Binding Proteins
;
administration & dosage
;
pharmacology
;
Down-Regulation
;
drug effects
;
genetics
;
Drug Resistance, Neoplasm
;
drug effects
;
Drug Screening Assays, Antitumor
;
methods
;
Drug Synergism
;
Esophageal Neoplasms
;
drug therapy
;
physiopathology
;
Fluorouracil
;
pharmacology
;
G1 Phase
;
drug effects
;
G2 Phase
;
drug effects
;
Humans
;
Metaphase
;
drug effects
;
RNA, Small Interfering
;
administration & dosage
;
pharmacology
;
Transfection
;
Ubiquitin-Protein Ligases
;
administration & dosage
;
pharmacology